Tridihexethyl Chloride

曲地氯铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTridihexethyl Chloride
Drug Alias Name季铵抗胆碱能氯化环已基羟苯丙基三乙胺氯化三乙己苯铵Pathilon
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPeptic Ulcer
Global Approved IndicationsPeptic Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1954/09/15
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesB. Lederle Gmbh
Active IndicationsN/A
Inactive IndicationsPeptic Ulcer

Other Information

ATC CodeA03AB08
Related LinksWikipediaDrugBankKEGG